CLIMA DE AULA
Fuente: Autoevaluación a la gestión del Aprendizaje del docente
cxxi
for HPR. The HIV-1 RNA copy number was then calculated from the specified input number of the QS RNA OD read at 450nm.
APPENDIX I
cxxii REFERENCES.
1 Oelkers W. Adrenal insufficiency. N Engl. J Med. 1996; 335(16): 1206—1212.
2 Addison T. On the constitutional and local effects of disease of the supra-renal capsules. London: Samuel Highley; 1855: 9
3 Alevritis EM, Sarubbi FA, Jordan RM, Peiris AN. Infectious causes of adrenal insufficiency. South Med J. 2003; 96(9): 888-890.
ivMurray CJL, Vos T, Lozano R. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990 - 2010: a systematic analysis for the Global Burden of Disease Study 2010.
5 Aron DC. Endocrine complications of the acquired immunodeficiency syndrome.
Arch Intern Med. 1989; 149(2): 330-333.
vi Shashidhar PK, Shashikala GV. Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients. indian J Endocrinol Metab. 2012; 16(3): 389–394.
7 Klatt EC, Nichols L, Noguchi TT. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. Arch Pathol. Lab Med. 1994; 118:
884–890.
8 Pillay D, Lipman MCI, Lee CA, Johnson MA, Griffiths PD, McLaughlin JE. A clinico-pathological audit of opportunistic viral infections in HIV-infected patients.
AIDS. 1993; 7: 969–974.
9 Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin. Pathol. 1990; 93: 651–656.
cxxiii
10 Glasgow BJ, Steinsapir KD, Anders K, Layfield LJ. Adrenal pathology in the acquired immune deficiency syndrome. Am J Clin Pathol .1985; 84(5): 594–597.
11 Greene LW, Cole W, Greene JB, Levy B, Louie E, Raphael B, et al. Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med. 1984; 101(4): 497-498.
xiiSoumya BS, Subrata S, Supratim G, Subhankar B.Addison's disease. Contemp Clin Dent.
2012; 3(4): 484 - 486.
13 George TG, Sylvester O, Nagelberg SB, Einhorn D, Talavera F, Chausmer BA, et al Addison’s Disease. e-medicine Endocrinology. cited 2010 April 5; Available from: http://emedicine.medscape.com/article/116467-overview
14 Willis AC, Vince FP .The prevalence of Addison’s disease in Coventry, UK. Postgrad Med J.1997; 73(859): 286 -288.
15 Soule S. Addison’s disease in Africa-a teaching hospital experience. Clin Endocrinol 1999; 50: 115-120.
16 Gordon WH, Dluhy RG. Disorders of the adrenal cortex. In: Fauci AS, Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL (eds). Harrison’s Principles of medicine
17thed. New York: McGraw-Hill Medical Publishing Division, 2008: 2247- 2269.
xviiHamilton DD, Cotton BA. Cosyntropin as a diagnostic agent in the screening of patients for
adrenocortical insufficiency. Clinical Pharmacology:Advances and Applications 2010; 2:77 - 82
18 Kyriazopoulou V. Glucocorticoid replacement therapy in patients with Addison's disease. Expert Opin Pharmacother. 2007; 8(6): 725-729.
19 Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Gudmundur J. Premature mortality in patients with Addison's disease: a population based study. J Clin Endocrinol Metab. 2006;
91(12): 4849- 4853.
cxxiv
xxYong SK, Eunhae K, Gee YS, Won-Jung K, Man PC, Hojoong K, Jung KO, et al . A Prospective Study on the Incidence and Predictive Factors of Relative Adrenal Insufficiency in Korean Critically-Ill Patients J Korean Med Sci. 2009 August; 24(4): 668 - 673.
21 Joint United Nations Programme on HIV/AIDS (UNAIDS). 2010 Report on the global AIDS epidemic. Geneva: UNAIDS. [cited 2011 Mar 18]; Available from:
http://www.unaids.org/GlobalReport/2010/2010_Global_report.asp
22 Federal Ministry of Health (2011). Technical report on the 2010 National HIV/Syphilis seroprevalence sentinel survey among pregnant women attending antenatal clinics in Nigeria. Department of Public Health National AIDS/STI Control Programme. Abuja, Nigeria: 13-18.
23 World Health Organisation. Global HIV/AIDS report 2008. Geneva WHO report 2008: 212-233.
24 Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988; 84(3): 611-616.
25 Welch K, Finkbeiner W, Alpers CE. Autopsy findings in acquired immune-deficiency syndrome. JAMA 1984; 252: 1152 - 1159.
26 Oelkers W, Diederich S, Bähr V. Recent advances in diagnosis and therapy of Addison’s disease. Dtsch. Med. Wochenschr. 1994; 119(115): 555-559.
27 Freda PU, Wardlaw SL, Brudney K, Goland RS. Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: a report of five cases. J Clin Endocrinol Metab 1994; 79(6): 1540-1545.
28 González-González JG, Garza-Hernández NE, Garza-Morán RA, Rivera-Morales IM, Montes-Villarreal J, Valenzuela-Rendón J, et al. Prevalence of abnormal adrenocortical function in human immunodeficiency virus infection by low-dose cosyntropin test. Int J STD AIDS. 2001; 12(12): 804-810.
29 Abbott M, Khoo, SH, Hammer MR, Wilkins EGL. Prevalence of cortisol deficiency in late HIV disease. J Infect. 1995; 31(1): 1-4.
30 Casado JL, Piedrola G, Lopez E. Adrenal Insufficiency in Patients with AIDS: When to Suspect It and How to Diagnose It. Patient Care and STDs. 1997; 11(5): 339 - 343.
cxxv
31 Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. Adenocortical function in Nigerian patients with pulmonary tuberculosis. Afr J Med Med Sci. 2011; 40(1): 33-38.
32 Meya DB, Katabira E, Otim M, Ronald A, Colebunders R, Njama D, et al. Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. . Afr Health Sci. 2007; 7(2): 101- 107.
33 National AIDS/STD control programme, FMOH. 2004 HIV/Syphilis sero- prevalence sentinel survey in Nigreria. Technical report, 2004.
xxxiv Stewart PM, Krone NP. The Adrenal Cortex. In: Shlomo M, Kenneth SP, Larsen PR,
Henry MK (eds). William’s textbook of endocrinology. 12thed. Elsevier Saunders Press.
2011: 479-544.
35 Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362.
32 Chrousos GP, Gold PW. The concepts of stress and stress system disorders.
Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
33 Conaglen JV, Donald RA, Espiner EA, Livesey JH, Nicholls MG. The effect of ovine corticotropin-releasing factor on catecholamine, vasopressin, and aldosterone secretion in normal man. J Clin Endocrinol Metab 1984; 58: 463-466.
35 Betterle C, Scalici C, Presotto F. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988; 117: 467.
cxxvi
36 Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987; 64: 494.
37 Moore PSJ, Couch RM, Perry YS, Shuckett EP, Winter JSD. Allgrove syndrome: an
autosomal recessive syndrome of ACTH insensitivity, achalasia and alacrima. Clin Endocrinol 1991; 34: 107- 114.
39 Marks JB. Endocrine manifestations of human immunodeficiency virus (HIV) infection.
Am J Med Sci. 1991; 302(2): 110-117.
40 Sahun VM, Villabona AC, Montana ME, Fernandez RJM, Soler RJ. The importance of
computerized axial tomography in the etiological diagnosis of Addison’s disease. Revista Clin Espanol 1992; 190: 177-180.
xliii Alebiosu CO and Odusan O. Addison’s disease: a case report. Annals Afri. Med. 2003;
2(2): 85-87.
42 Fauci AS, Lane CH. Human immunodeficiency virus disease: AIDS and related disorders. In: Fauci AS, Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL (eds).
Harrison’s Principles of medicine. 17thed. New York: McGraw-Hill Medical Publishing Division, 2008: 1137- 1204.
43 Meloni ST, Ojesina A, Olaleye DO. The molecular epidemiology of HIV. In: Adeyi O, Kanki PJ, Odutolu O, Idoko JA (eds). AIDS in Nigeria. Boston: Harvard Centre for population and development studies. 2006: 67-93.
44 Grant A, atabira ET, Marum LH, De-Cock KM. HIV/AIDS. In: Parry E, Godfrey R, Mabey D, Gill G (eds). Principles of Medicine in Africa.3rded. Edinburgh: Cambridge University Press. 2004: 284-304.
45 Idoko JA, Njoku O, Edubio A. Molecular epidemiology of HIV-1 in North-central Nigeria. Abstract, 13th International Conference on AIDS and STIs in Africa, Nairobi, Kenya, September 2003.
cxxvii
46 Fauci AS, Schnittman SM, Guido P, Koenig S, Giuseppe P. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114(8): 678-693.
47 Adeyi O, Kanki PJ, Odutolu O, Idoko JA. AIDS in Nigeria. 1st ed, Cambridge:
Havard Centre For Population and Development Studies 2006; 72, 68, 134-137, 342,390-408.
lUnachukwu CN, Uchenna DI, Young EE. Endocrine and metabolic disorders associated with human immune deficiency virus infection. West Afr J Med. 2009; 28(1): 3-9
li Wolff FH, Nhuch C, Cadore LP, Glitz CL, Lhullier F, Furlanetto TW. Low-dose
adrenocorticotropin test in patients with the acquired immunodeficiency syndrome. Braz J Infect Dis. 2001; 5(2): 53- 59.
lii Etzel JV, Brocavich JM, Torre M. Endocrine complications associated with human immunodeficiency virus infection. Clin Pharm. 1992; 11(8):705-713.
liii Villette JM, Bourin P, Doniel C. Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus.
J Clin Endocrinol Metab 1990; 70: 572-577.
52 Odelia BC, Todd TB, Adrian SD. Opiate Drug Use: A Potential Contributor to the Endocrine and Metabolic Complications in Human immunodeficiency virus disease.
Clin Infect Dis. 2003; 37(suppl 2): S132-S136.
53 Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome.
Endocr Rev. 1996; 17(5): 518- 532.
54 Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988; 158:
449–456.
55 Fujii K, Morimoto I, Wake A, Okada Y, Inokuchi N, Ishida O, et al. Adrenal insufficiency in a patient with acquired immunodeficiency syndrome. Endocr J 1994;
41(1): 13–18.
cxxviii
56 Grinspoon SK, Bilezikian JP, Donovan DS. HIV disease and the endocrine system. N
Engl J Med 1992; 327: 1360-1365.
57 Bricaire F, Marche C, Zoubi D, Regnier B, Saimot AG. Adrenocortical lesions and AIDS. Lancet 1988; 1: 881.
58 Hilton CW, Harrington PT, Prasad C, Svec F. Adrenal insufficiency in the acquired immunodeficiency syndrome. South Med J. 1988; 81(12): 1493-1495.
59 Norbiato G, Galli M, Righini V, Moroni M. The syndrome of acquired glucocorticoid resistance in HIV infection. Baillieres Clin Endocrinol Metab 1994; 8: 777-787.
60 Carta S, Olivieri A, Sorcini M, Medda E, Fazzini C, Battisti P, Sorcini I, Grandolfo ME. Endocrine response to HIV infection. Involvement of thyroid gland. Ann Ist Super Sanita. 1993; 29(3): 451 -456.
61 Schlienger JL, Lang JM. Endocrine consequences of infection by human immunodeficiency virus (HIV). Pathol Biol. 1989; 37(8): 921- 926.
62 Mark SC, Paul MS. Corticosteroid Insufficiency in Acutely Ill Patients Engl J Med 2003; 348: 727-734.
63 Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY, Combination IL-2 and IL-4 reduce glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993 151: 3460-3466.
lxvi Evangelia Z, Konstantinos T, George C. Dysfunction of the Hypothalamic-Pituitary-Adrenal axis in HIV infection and disease. HORMONES 2008; 7(3): 205-216.
65 Malone JL, Oldfield EC, Wagner KF. Abnormalities of morning serum cortisol levels and circadian rhythms of CD4 lymphocyte counts in human immunodeficiency virus type 1 infected adult patients. J Infect Dis 1992; 162: 185-186.
lxviiiFerreiro J and Vinters HV. Pathology of the pituitary gland in patients with the acquired
immune deficiency syndrome (AIDS).Pathology. 1988; 20: 211-215.
67 Centers for Disease Control. Revision of CDC surveillance case definition of acquired immunodeficiency syndrome. MMWR. 1987; 36(suppl 1S):S3-S14.
cxxix
68 Population of Nigeria. www.nigerianstat.gov.ng/connections/pop2006.pdf accessed
23rd June, 2010.
69 Oyejide CO. Health research methods for developing countries scientists. First edition Ibadan: Macmillan, 1992; 5: 60-63.
lxxiiWHO Technical Report Series-854. Physical Status: The use and interpretation of
Anthropometry, WHO Geneva 1995.
lxxiii. Smolyar D, Tirado-Bernardini R, Landman R, Lesser M, Young I, Poretsky L.
Comparison of 1μg and 250μg Corticotropin Stimulation Tests for the Evaluation of Adrenal Function in Patients With Acquired Immunodeficiency Syndrome. Metabolism 2003; 52 (5):
647-651.
lxxiv Kaplan FJL, Levitt NS, Soule SG: Primary hypoadrenalism assessed by the 1μg ACTH
test in hospitalized patients with active pulmonary tuberculosis. Q J Med 2000; 93: 603-609.
lxxv Centres for Disease Control and prevention. 1993 Revised classification for HIV
infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993; 41: 1-19.
lxxviKricka LJ. Principles of Immunochemical Techniques. In: Burtis CA, Ashwood ER, Bruns
DE (eds ). TIETZ Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed.
Elsevier Sanders Press. 2006: 219 - 243.
lxxvii Beishuizen A, Thijs LG. Relative adrenal failure in intensive care: an identifiable problem requiring
treatment? Best Pract Res Clin Endocrinol Metab. 2001; 15 : 513 - 531.
lxxviii Reichert CM, O’Leary TJ, Levens DL. Autopsy pathology in the acquired immune
deficiency syndrome. Am J Pathol 1983; 112:357- 382.
cxxx
lxxix Hoshimo Y, Yamasshita N, Nakumura T, Iwamoto A. Prospective Examination of
adrenocortical function in advanced AIDS patients. Endocrine Journal 2002; 49(6):641----647.
lxxx Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1μg) adreno-corticotropin test in the evaluation of patients with Pituitary diseases. J Clin Endocrinol Metab. 1995;80:1301–1305.]
lxxxi Arafah BM. Review: Hypothalamic pituitary adrenal function during critical illness:
Limitations of current assessment methods. J Clin Endocrinol Metab. 2006;91:3725–3745.
lxxxii Paul E. Marik, MD, Kitonga K, Gary P, Zaloga, MD. Adrenal insufficiency in critically
ill patients with human immunodeficiency virus. Crit Care Med 2002; 30(6):1267–1273)
lxxxiii Ekpebegh CO, Ogbera AO, Longo-Mbenza B, Blanco-Blanco E, Awotedu A, Oluboyo
P. Basal Cortisol Levels and Correlates of Hypoadrenalism in Patients with Human Immunodeficiency Virus Infection. Med Princ Pract 2011;20:525–529.
lxxxivHawken MP, Ojoo JC, Morris JS. No increased prevalence of adrenocortical insufficiency
in human immunodeficiency virus-associated tuberculosis. Tubercle and Lung Disease. 1996
; 77: 444- 448.
lxxxvPrasanthai V, Sunthornyothin S, Phowthongkum P, Suankratay C. Prevalence of
adrenal insufficiency in critically ill patients with AIDS. J Med. Assoc. Thai. 2007;
90(9): 1768 - 1774 .
lxxxvi Membreno L, Irony I, Dere W. Adrenocortical function in acquired immune deficiency
syndrome. J Clin. Endocrinol. Metab. 1987; 65: 482- 487.